Citius Oncology, Inc. (CTOR) — Capital Reinvestment Ratio
Latest as of September 2024:
0.00x
Citius Oncology, Inc. (CTOR) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($900.29K) in capital expenditures ($0.46). See Citius Oncology, Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$900.29K
USD
Capital Expenditures
$0.46
USD
Data as of
Sep 2024
Most recent filing
Citius Oncology, Inc. Capital Reinvestment Ratio (2024–2024)
This chart tracks Citius Oncology, Inc.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Citius Oncology, Inc. (2024–2024)
Year-by-year Capital Reinvestment Ratio for Citius Oncology, Inc. from 2024 to 2024. For live market cap and broader valuation context, see CTOR company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $126.35K | $4.00 | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow